Articles tagged "Liver transplantation"

2020 American Transplant Congress
Graft Survival after Liver Transplantation for Patients with Cholangiocarcinoma
I. A. Ziogas, L. A. Hickman, L. K. Matsuoka, M. I. Montenovo, M. Izzy, S. A. Rega, I. D. Feurer, S. P. Alexopoulos
Vanderbilt University Medical Center, Nashville, TN
*Purpose: Liver transplantation (LT) with neoadjuvant chemoradiation is increasingly utilized for the treatment for unresectable cholangiocarcinoma (CCA), however, post-LT graft survival is not well described.…
2020 American Transplant Congress
A Multidisciplinary Protocol for the Management of Hyponatremia at the Time of Liver Transplantation is Associated with Reduced Post-Transplant Neurologic Complications
J. F. Crismale, T. Huisman, R. Deshpande, C. Law, G. Im, D. Bronster, S. Demaria Jr, S. Florman, T. Schiano
Mount Sinai, New York, NY
*Purpose: The primary purpose of this study was to assess whether implementation of a multidisciplinary protocol (Figure 1) aimed at limiting rapid changes in serum…
2020 American Transplant Congress
Totally Robotic Living Donor Hepatectomy Graft Parenchymal Transection Time
Y. L. Cheah, J. Kim, C. J. Simon, S. Meade, R. Jenkins, M. E. Akoad
Lahey Hospital & Medical Center, Burlington, MA
*Purpose: Evaluate duration of parenchymal transection in a series of totally robotic living donor hepatectomies in order to improve time coordination between living donor and…
2020 American Transplant Congress
Domino Transplantation – Expanding the Liver Donor Pool to the Pediatric Recipient
U. Ekong¹, N. Yazigi¹, K. Khan¹, S. Kaufman¹, K. Chapman², E. Leon², N. Ah Mew², A. Kroemer¹, R. Girlanda¹, J. Hawksworth¹, C. Matsumoto¹, T. Fishbein¹
¹MedStar Georgetown Transplant Institute, Washington, DC, ²Genetics, Children's National Hospital, Washington, DC
*Purpose: Background: Maple syrup urine disease (MSUD) is an inherited autosomal recessive metabolic disorder of amino acid metabolism, caused by a defect of the branched-chain…
2020 American Transplant Congress
The Association between Infection and Important Clinical Outcomes in Acute-On-Chronic Liver Patients Admitted to ICU: A Single Center Cohort Analysis
M. Kim¹, A. Pawlowski², R. G. Wunderink³, D. P. Ladner⁴, C. J. Karvellas⁵
¹Neurology, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL, ³Medicine, Northwestern University, Chicago, IL, ⁴Surgery, Northwestern University, Chicago, IL, ⁵Medicine, University of Alberta, Edmonton, AB, Canada
*Purpose: One of the most common precipitants of acute on chronic liver failure (ACLF) in cirrhotic patients is sepsis. We aimed to evaluate the relationship…
2020 American Transplant Congress
The Strategy and Utility of Checkpoint Inhibitor Therapy in Patient with Hepatocellular Carcinoma Recurrence Following Liver Transplantation
L. Jeng, S. Hsu, A. Thorat
China Medical University Hospital, Taichung, Taiwan
*Purpose: Checkpoint inhibitor therapy is a hot and rapidly progressive therapy in advanced cancer patients in the past 2 years. Although some successful case report…
2020 American Transplant Congress
Marijuana Use Among Liver Transplant Recipients
K. G. Yan, L. Forman
Internal Medicine, University of Colorado School of Medicine, Aurora, CO
*Purpose: The effect of marijuana (MJ) use on liver transplant (LTx) outcomes is unclear. We aimed to investigate the prevalence of MJ and cannabidiol (CBD)…
2020 American Transplant Congress
Hif-1a Expression Influences Recipient Clinical Outcomes in Liver Transplant Patients
K. Kadono, T. Ito, H. Kojima, K. Nakamura, H. Hirao, S. Kageyama, K. J. Dery, A. Murray, R. W. Busutill, F. Kaldas, J. W. Kupiec-Weglinski
Liver Transplant Surgery, UCLA, Los Angeles, CA
*Purpose: Liver ischemia-reperfusion injury (IRI), an innate-immune dominated hepatocellular damage, is a risk factor for early allograft dysfunction (EAD) and rejection crises in liver transplantation…
2020 American Transplant Congress
Molecular Diagnosis of Rejection in Liver Transplant Biopsies: The INTERLIVER Study
K. S. Madill-Thomsen¹, P. F. Halloran², .. The INTERLIVER Study Group³
¹Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada, ²University of Alberta, Edmonton, AB, Canada, ³., ., AB, Canada
*Purpose: Diagnosing rejection in liver transplant biopsies is challenging given the limitations of histology e.g. low kappa values among pathologists. A Molecular Microscope® Diagnostic system…
2020 American Transplant Congress
Cardiovascular Risk Factors in Patients after Liver Transplantion
M. Adamczak¹, D. Gojowy¹, J. Stompor¹, J. Adamusik¹, G. Smiech¹, H. Karkoszka¹, R. Krol², A. Wiecek¹
¹Department of Nephrology, Transplantation and Internal Medicine, Medical University of Silesia, Katowice, Poland, ²Department of General, Vascular and Transplant Surgery, Medical University of Silesia, Katowice, Poland
*Purpose: The aim of this study was to estimate the prevalence of selected cardiovascular risk factors in patients after liver transplantation (LTx).*Methods: Medical records from…